(Q22242870)

https://api.crossref.org/works/10.1093%2FHMG%2FDDP012

Present and future drug treatment for Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDP012

Mutation in the alpha-synuclein gene identified in families with Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDP012

Alpha-synuclein in Lewy bodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDP012

alpha-Synuclein in filamentous inclusions of Lewy bodies from Parkinson's disease and dementia with lewy bodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDP012

Ala30Pro mutation in the gene encoding alpha-synuclein in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDP012

The new mutation, E46K, of alpha-synuclein causes Parkinson and Lewy body dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDP012

Alpha-synuclein and Parkinson's disease: Implications from the screening of more than 1,900 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDP012

alpha-Synuclein locus triplication causes Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDP012

Comparison of kindreds with parkinsonism and alpha-synuclein genomic multiplications

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDP012

Alpha-synuclein locus duplication as a cause of familial Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDP012

Clinical heterogeneity of alpha-synuclein gene duplication in Parkinson's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDP012

Phenotypic variation in a large Swedish pedigree due to SNCA duplication and triplication.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDP012

alpha-Synuclein gene duplication is present in sporadic Parkinson disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDP012

Patients homozygous and heterozygous for SNCA duplication in a family with parkinsonism and dementia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDP012

Genomic investigation of alpha-synuclein multiplication and parkinsonism

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDP012

Alpha-synuclein gene rearrangements in dominantly inherited parkinsonism: frequency, phenotype, and mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDP012

Prominent psychiatric symptoms and glucose hypometabolism in a family with a SNCA duplication

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDP012

Type and frequency of mutations in the LRRK2 gene in familial and sporadic Parkinson's disease*.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDP012

Mutations in the gene LRRK2 encoding dardarin (PARK8) cause familial Parkinson's disease: clinical, pathological, olfactory and functional imaging and genetic data

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDP012

Comprehensive analysis of the LRRK2 gene in sixty families with Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDP012

Comprehensive screening of a North American Parkinson's disease cohort for LRRK2 mutation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDP012

LRRK2 mutation analysis in Parkinson disease families with evidence of linkage to PARK8.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDP012

G2019S LRRK2 mutation in French and North African families with Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDP012

Escaping Parkinson's disease: a neurologically healthy octogenarian with the LRRK2 G2019S mutation

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDP012

Leucine-rich repeat kinase 2 (LRRK2) mutations in a Swedish Parkinson cohort and a healthy nonagenarian

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDP012

Frequency of LRRK2 mutations in early- and late-onset Parkinson disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDP012

LRRK2 G2019S as a cause of Parkinson's disease in Ashkenazi Jews.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDP012

Genetic screening of the G2019S mutation of the LRRK2 gene in Southwest European, North African, and Sephardic Jewish subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDP012

Corticobasal syndrome and primary progressive aphasia as manifestations of LRRK2 gene mutations

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDP012

The G2019S LRRK2 mutation is uncommon in an Asian cohort of Parkinson's disease patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDP012

Absence/rarity of commonly reported LRRK2 mutations in Indian Parkinson's disease patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDP012

Analysis of Nigerians with apparently sporadic Parkinson disease for mutations in LRRK2, PRKN and ATXN3.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDP012

The LRRK2 gene in Parkinson's disease: mutation screening in patients from Germany

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDP012

The prevalence of the G2019S and R1441C/G/H mutations in LRRK2 in German patients with Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDP012

The LRRK2 G2019S mutation in Ashkenazi Jews with Parkinson disease: is there a gender effect?

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDP012

Screening for Lrrk2 G2019S and clinical comparison of Tunisian and North American Caucasian Parkinson's disease families

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDP012

Is the common LRRK2 G2019S mutation related to dyskinesias in North African Parkinson disease?

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDP012

LRRK2 haplotype analyses in European and North African families with Parkinson disease: a common founder for the G2019S mutation dating from the 13th century

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDP012

Identification of a novel LRRK2 mutation linked to autosomal dominant parkinsonism: evidence of a common founder across European populations

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDP012

LRRK2 G2019S in families with Parkinson disease who originated from Europe and the Middle East: evidence of two distinct founding events beginning two millennia ago.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDP012

A founding LRRK2 haplotype shared by Tunisian, US, European and Middle Eastern families with Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDP012

The Gly2019Ser mutation in LRRK2 is not fully penetrant in familial Parkinson's disease: the GenePD study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDP012

Digenic parkinsonism: investigation of the synergistic effects of PRKN and LRRK2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDP012

Clinical features of Parkinson disease patients with homozygous leucine-rich repeat kinase 2 G2019S mutations.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDP012

Kufor-Rakeb syndrome, pallido-pyramidal degeneration with supranuclear upgaze paresis and dementia, maps to 1p36

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDP012

Hereditary parkinsonism with dementia is caused by mutations in ATP13A2, encoding a lysosomal type 5 P-type ATPase

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDP012

PARK9-LINKED PARKINSONISM IN EASTERN ASIA: MUTATION DETECTION IN ATP13A2 AND CLINICAL PHENOTYPE

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDP012

ATP13A2 missense mutations in juvenile parkinsonism and young onset Parkinson disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDP012

Novel ATP13A2 variant associated with Parkinson disease in Taiwan and Singapore

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDP012

Deciphering the role of heterozygous mutations in genes associated with parkinsonism

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDP012

Mutations in the glucocerebrosidase gene and Parkinson disease: phenotype-genotype correlation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDP012

The role of autophagy-lysosome pathway in neurodegeneration associated with Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDP012

Genome screen to identify susceptibility genes for Parkinson disease in a sample without parkin mutations

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDP012

Significant linkage of Parkinson disease to chromosome 2q36-37

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDP012

Mutations in the GIGYF2 (TNRC15) gene at the PARK11 locus in familial Parkinson disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDP012

Two novel proteins that are linked to insulin-like growth factor (IGF-I) receptors by the Grb10 adapter and modulate IGF-I signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDP012

Lack of replication of association between GIGYF2 variants and Parkinson disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDP012

Loss of function mutations in the gene encoding Omi/HtrA2 in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDP012

Loss of Omi mitochondrial protease activity causes the neuromuscular disorder of mnd2 mutant mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDP012

Neuroprotective role of the Reaper-related serine protease HtrA2/Omi revealed by targeted deletion in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDP012

Sequencing analysis of OMI/HTRA2 shows previously reported pathogenic mutations in neurologically normal controls

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDP012

Genetic variation of Omi/HtrA2 and Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDP012

Genetic variability in the mitochondrial serine protease HTRA2 contributes to risk for Parkinson disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDP012

The mitochondrial protease HtrA2 is regulated by Parkinson's disease-associated kinase PINK1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDP012

A susceptibility locus for Parkinson's disease maps to chromosome 2p13.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDP012

A susceptibility gene for late-onset idiopathic Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDP012

Genome-wide linkage analysis of a Parkinsonian-pyramidal syndrome pedigree by 500 K SNP arrays

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDP012

PLA2G6, encoding a phospholipase A2, is mutated in neurodegenerative disorders with high brain iron

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDP012

Neurodegeneration associated with genetic defects in phospholipase A(2).

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDP012

Genetic anticipation in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDP012

Molecular and clinical correlations in spinocerebellar ataxia 2: a study of 32 families

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDP012

SCA2 may present as levodopa-responsive parkinsonism

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDP012

Presence of spinocerebellar ataxia type 2 gene mutation in a patient with apparently sporadic Parkinson's disease: clinical implications.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDP012

Analysis of SCA-2 and SCA-3 repeats in Parkinsonism: evidence of SCA-2 expansion in a family with autosomal dominant Parkinson's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDP012

Importance of low-range CAG expansion and CAA interruption in SCA2 Parkinsonism.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDP012

Prevalence of spinocerebellar ataxia type 2 mutation among Italian Parkinsonian patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDP012

Profile of families with parkinsonism-predominant spinocerebellar ataxia type 2 (SCA2).

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDP012

The parkinsonian phenotype of spinocerebellar ataxia type 2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDP012

CAG repeat instability at SCA2 locus: anchoring CAA interruptions and linked single nucleotide polymorphisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDP012

Multiple regions of alpha-synuclein are associated with Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDP012

Multiple candidate gene analysis identifies alpha-synuclein as a susceptibility gene for sporadic Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDP012

alpha-Synuclein promoter confers susceptibility to Parkinson's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDP012

Growth hormone treatment in short Japanese children born small for gestational age.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDP012

Effect of allelic variation at the NACP-Rep1 repeat upstream of the alpha-synuclein gene (SNCA) on transcription in a cell culture luciferase reporter system

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDP012

Tau and alpha-synuclein in susceptibility to, and dementia in, Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDP012

Interface between tauopathies and synucleinopathies: A tale of two proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDP012

A common genetic factor for Parkinson disease in ethnic Chinese population in Taiwan

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDP012

Lrrk2 G2385R is an ancestral risk factor for Parkinson's disease in Asia

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDP012

The LRRK2 Gly2385Arg variant is associated with Parkinson's disease: genetic and functional evidence.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDP012

The prevalence of LRRK2 Gly2385Arg variant in Chinese Han population with Parkinson's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDP012

Leucine-rich repeat kinase 2 G2385R variant is a risk factor for Parkinson disease in Asian population.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDP012

LRRK2 Gly2385Arg mutation and clinical features in a Chinese population with early-onset Parkinson's disease compared to late-onset patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDP012

LRRK2 Gly2385Arg variant is a risk factor of Parkinson's disease among Han-Chinese from mainland China

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDP012

Analysis of PARK genes in a Korean cohort of early-onset Parkinson disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDP012

Essential tremor and the common LRRK2 G2385R variant.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDP012

Analysis of the LRRK2 Gly2385Arg variant in primary dystonia and multiple system atrophy in Taiwan

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDP012

Analysis of Lrrk2 R1628P as a risk factor for Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDP012

The LRRK2 Arg1628Pro variant is a risk factor for Parkinson's disease in the Chinese population

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDP012

Lrrk2 R1628P in non-Chinese Asian races

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDP012

Mutations in the glucocerebrosidase gene and Parkinson's disease in Ashkenazi Jews

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDP012

Glucocerebrosidase mutations in subjects with parkinsonism

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDP012

Analysis of the glucocerebrosidase gene in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDP012

Glucocerebrosidase gene mutations and Parkinson disease in the Norwegian population.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDP012

Mutations in the glucocerebrosidase gene are associated with early-onset Parkinson disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDP012

Glucocerebrosidase gene mutation is a risk factor for early onset of Parkinson disease among Taiwanese

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDP012

Glucocerebrosidase mutations in Chinese subjects from Taiwan with sporadic Parkinson disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDP012

Glucocerebrosidase gene mutations are associated with Parkinson's disease in southern Italy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDP012

Glucocerebrosidase mutations are an important risk factor for Lewy body disorders.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDP012

Glucocerebrosidase gene mutations: a risk factor for Lewy body disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDP012

New genetic insights into Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDP012

Neuropathology provides clues to the pathophysiology of Gaucher disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDP012

High-resolution whole-genome association study of Parkinson disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDP012

Genome-wide genotyping in Parkinson's disease and neurologically normal controls: first stage analysis and public release of data

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDP012

Considerations for genomewide association studies in Parkinson disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDP012

Meta-analysis in genome-wide association datasets: strategies and application in Parkinson disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDP012

Genomewide association study for susceptibility genes contributing to familial Parkinson disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDP012

Beyond Parkinson disease: amyotrophic lateral sclerosis and the axon guidance pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDP012

Neither replication nor simulation supports a role for the axon guidance pathway in the genetics of Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDP012

The Ala53Thr mutation in the α-synuclein gene in a Korean family with Parkinson disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDP012

Identification and haplotype analysis of LRRK2 G2019S in Japanese patients with Parkinson disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDP012

Genome-wide linkage analysis and evidence of gene-by-gene interactions in a sample of 362 multiplex Parkinson disease families

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDP012

Lrrk2 pathogenic substitutions in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDP012

LRRK2 mutations in Parkinson disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDP012

Are interruptedSCA2CAG repeat expansions responsible for parkinsonism?

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDP012

alpha-synuclein gene haplotypes are associated with Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDP012

Collaborative Analysis of α-Synuclein Gene Promoter Variability and Parkinson Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDP012

-Synuclein, pesticides, and Parkinson disease: A case-control study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDP012

LRRK2 mutation in familial Parkinson’s disease in a Taiwanese population: clinical, PET, and functional studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDP012

LRRK2G2019S as a Cause of Parkinson's Disease in North African Arabs

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDP012

A frequent LRRK2 gene mutation associated with autosomal dominant Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDP012

Clinical and pathological features of a parkinsonian syndrome in a family with an Ala53Thr ?-synuclein mutation

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDP012

7 January 2021

Comprehensive analysis of LRRK2 in publicly available Parkinson's disease cases and neurologically normal controls

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDP012

7 January 2021

Association of alpha-synuclein Rep1 polymorphism and Parkinson's disease: influence of Rep1 on age at onset

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDP012

7 January 2021

Lack of G2019S LRRK2 mutation in a cohort of Taiwanese with sporadic Parkinson's disease

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDP012

7 January 2021

Recurrent LRRK2 (Park8) mutations in early-onset Parkinson's disease

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDP012

7 January 2021

Comparing LRRK2 Gly2385Arg carriers with noncarriers

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDP012

7 January 2021

Analysis of LRRK2 Gly2385Arg genetic variant in non-Chinese Asians

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDP012

7 January 2021

The utility F-box for protein destruction

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDP012

7 January 2021

LRRK2 R1628P increases risk of Parkinson's disease: replication evidence

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDP012

7 January 2021

Polymorphisms of the alpha-synuclein promoter: expression analyses and association studies in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDP012

7 January 2021

A common missense variant in the LRRK2 gene, Gly2385Arg, associated with Parkinson's disease risk in Taiwan

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDP012

7 January 2021

Analysis of LRRK2 G2019S and I2020T mutations in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDP012

7 January 2021

Genetic analysis of SCA2, 3 and 17 in idiopathic Parkinson's disease

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDP012

7 January 2021

Glucocerebrosidase mutations are not found in association with LRRK2 G2019S in subjects with parkinsonism

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDP012

7 January 2021

The LRRK2 I2012T, G2019S, and I2020T mutations are rare in Taiwanese patients with sporadic Parkinson's disease

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDP012

7 January 2021

Association between Parkinson's disease and glucocerebrosidase mutations in Brazil

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDP012

7 January 2021

Causal relation between alpha-synuclein gene duplication and familial Parkinson's disease

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDP012

7 January 2021

LRRK2 Gly2019Ser penetrance in Arab-Berber patients from Tunisia: a case-control genetic study

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDP012

7 January 2021

Phenotype, genotype, and worldwide genetic penetrance of LRRK2-associated Parkinson's disease: a case-control study

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDP012

7 January 2021

The glucocerebrosidase gene and Parkinson's disease in Ashkenazi Jews

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDP012

7 January 2021

Neuropathology of Parkinson's disease

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDP012

7 January 2021

How genetics research in Parkinson's disease is enhancing understanding of the common idiopathic forms of the disease

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDP012

7 January 2021

Screening for SNCA and LRRK2 mutations in Greek sporadic and autosomal dominant Parkinson's disease: identification of two novel LRRK2 variants

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDP012

7 January 2021

Neurological signs: Behçet's disease, coeliac disease, both, or neither?

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDP012

7 January 2021

The G2019S LRRK2 mutation is uncommon amongst Greek patients with sporadic Parkinson's disease

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDP012

7 January 2021

Non-motor symptoms in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDP012

7 January 2021

Evaluation of LRRK2 G2019S penetrance: Relevance for genetic counseling in Parkinson disease

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDP012

7 January 2021

Clinicopathologic study of a SNCA gene duplication patient with Parkinson disease and dementia

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDP012

7 January 2021

Genotype-phenotype correlations between GBA mutations and Parkinson disease risk and onset

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDP012

7 January 2021

https://api.crossref.org/works/10.1093%2FHMG%2FDDP012

1 reference

7 January 2021

Re: Alpha-synuclein gene duplication is present in sporadic Parkinson disease

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDP012

7 January 2021

Rhomboid-7 and HtrA2/Omi act in a common pathway with the Parkinson's disease factors Pink1 and Parkin

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDP012

7 January 2021